Why did Nvidia hit $4 trillion valuation?
How will Trump’s tariffs affect US trade?
What caused the spike in US copper prices?
Why is X CEO Linda Yaccarino stepping down?
How are AI investments impacting tech jobs?
What is the impact of federal workforce cuts?
Why is Amazon extending Prime Day discounts?
I-Mab Presents Promising Phase 1b Givastomig Combination Data for Gastric Cancers at ESMO GI 2025
finance.yahoo.com/news/mab-presents-promising-phase-1b-112004537.html
In This Article:
I-Mab (NASDAQ:IMAB) is one of the best-performing NASDAQ stocks according to analysts. On July 2, I-Mab announced the presentation of positive Phase 1b combination data for givastomig at the European Society for Medical Oncology Gastrointestinal Cancers Congress 2025…
This story appeared on finance.yahoo.com, 2025-07-09 11:20:04.